These findings are again in line with observations in cancer cells, where AK4 knockdown improved mitochondrial activity (increased maximal respiratory capacity after FCCP treatment) and prevented a glycolytic shift (decreased HK2 and lactate levels), leading ultimately to reduced proliferative/metastatic potential [30,35]. Here, AK4 is linked to cancer.